ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 90 filers reported holding ATHIRA PHARMA INC in Q2 2021. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,499,533 | -36.8% | 742,343 | -7.7% | 0.00% | 0.0% |
Q2 2023 | $2,373,051 | +178324.9% | 804,424 | +51.2% | 0.00% | 0.0% |
Q1 2023 | $1,330 | +1056.5% | 531,941 | +1360.3% | 0.00% | – |
Q4 2022 | $115 | -99.9% | 36,426 | +27.8% | 0.00% | – |
Q3 2022 | $85,000 | -19.0% | 28,512 | -16.9% | 0.00% | – |
Q2 2022 | $105,000 | -80.2% | 34,308 | -33.8% | 0.00% | – |
Q2 2021 | $531,000 | -94.3% | 51,843 | -89.8% | 0.00% | -100.0% |
Q1 2021 | $9,391,000 | +166.6% | 510,395 | +396.3% | 0.01% | +133.3% |
Q4 2020 | $3,522,000 | -15.4% | 102,846 | -54.4% | 0.00% | -40.0% |
Q3 2020 | $4,163,000 | – | 225,492 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 1,630,744 | $21,249,000 | 2.19% |
VR Adviser, LLC | 1,000,000 | $13,030,000 | 1.78% |
ACUTA CAPITAL PARTNERS, LLC | 310,030 | $4,040,000 | 1.70% |
Ikarian Capital, LLC | 860,000 | $11,207,000 | 1.67% |
Bristlecone Advisors, LLC | 761,563 | $9,923,000 | 1.19% |
Perceptive Advisors | 6,851,832 | $89,280,000 | 0.69% |
DAFNA Capital Management LLC | 160,983 | $2,098,000 | 0.53% |
PATHSTONE FAMILY OFFICE, LLC | 1,442,247 | $18,792,000 | 0.47% |
Potomac Capital Management, Inc. | 40,000 | $521,000 | 0.46% |
RTW INVESTMENTS, LP | 1,906,557 | $24,842,000 | 0.36% |